Seegene Inc., a leading South Korean company providing a total solution for PCR molecular diagnostics, has declared the commencement of sharing its syndromic PCR technologies all over the world. Seegene aims to partner with nationally reputable companies in each country to develop and manufacture customised syndromic PCR tests locally through access to Seegene's proprietary technologies and know-how.

This effort will enable partnering companies to effectively address potential disease outbreaks and collaboratively prevent future pandemics.

Embracing an open innovation model, Seegene invites leading companies in each country to join this network and collectively develop hundreds or even thousands of syndromic PCR assays annually to serve both local and global markets. The creation of a sustainable global community will catalyse the development of novel and innovative applications for PCR technologies worldwide.

Seegene recently signed the first One System global partnership agreement with the leading diagnostic company in Israel, Hy Laboratories.